CASI Pharmaceuticals

CASI

Market cap $20.9M

1.35 USD

+0.02

1.5%

At close Updated Nov 5, 4:00 PM EST

Pre-market

After hours

1.33

--0.02

1.48%

1 day

1.5%

5 days

-11.18%

1 month

-26.23%

3 months

-30.41%

6 months

-29.69%

Year to date

-54.7%

1 year

-77.35%

5 years

-93.22%

10 years

-88.75%

About: CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Employees: 233

Healthcare Biotechnology